Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)

PHASE2CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

March 31, 2023

Study Completion Date

August 31, 2024

Conditions
Mycosis FungoidesSezary SyndromeLymphoma, T-Cell, Cutaneous
Interventions
DRUG

resminostat

DRUG

Placebo

Trial Locations (54)

Unknown

Medizinische Universität Graz, Graz

Medizinische Universität Wien, Vienna

Cliniques Universitaires Saint-Luc, Brussels

Universitaire Ziekenhuizen, Leuven

Centre Hospitalier Universitaire (CHU) de Bordeaux - Hôpital Saint-André, Bordeaux

CHU Estaing, Clermont-Ferrand

Centre Hospitalier Lyon-Sud, Lyon

Chu Paris-Gh St-Louis Lariboisiere F.Widal Hopital, Paris

Hopital Robert Debre - CHU de Reims, Reims

Charité - Universitaetsmedizin Berlin, Berlin

Universitaetsklinikum Bochum - St. Josef-Hospital, Bochum

Elbekliniken Buxtehude, Buxtehude

Uniklinik Köln, Cologne

Klinikum Dortmund, Dortmund

SRH Wald-Klinikum Gera, Gera

Universitätsmedizin Göttingen, Göttingen

Universitaetsklinikum Halle, Halle

Universitaetsklinikum Hamburg-Eppendorf, Hamburg

Universitaetsklinikum Schleswig-Holstein (UKSH), Campus Kiel, Kiel

HELIOS Klinikum, Krefeld

Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen am Rhein

Universitätsklinikum Schleswig-Holstein, Lübeck

Universitätsklinikum Mannheim, Mannheim

Johannes Wesling Klinikum Minden, Minden

Universitäts-Hautklinik Tübingen, Tübingen

Universitätsklinikum Ulm, Ulm

ATTIKON Hospital and Cutaneous Lymphoma Clinic, Athens

Universita Di Firenze, Florence

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan

Universita Cattolica del Sacro Cuore, Roma

IFO San Gallicano, Rome

Ospedale Molinette, Turin

Niigata University Medical and Dental Hospital, Niigata

Okayama University Hospital, Okayama

Tohoku University Hospital, Sendai

Hamamatsu University School of Medicine, Shizuoka

University of Tsukuba Hospital, Tsukuba

Leids Universitair Medisch Centrum (LUMC), Leiden

Medical University of Gdansk, Gdansk

SP ZOZ Szpital Uniwersytecki w Krakowie, Krakow

Uniwersytecki Szpital Kliniczny im. WAM - CSW, Lodz

Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warsaw

Hospital Del Mar, Barcelona

Hospital Duran i Reynals, Barcelona

Hospital Universitario 12 de Octubre, Madrid

Hospital Uni. Nuestra Senora de Candelaria, Santa Cruz de Tenerife

Hospital General Universitario, Valencia

Centre hospitalier universitaire vaudois (CHUV), Lausanne

Kantonsspital St. Gallen, Sankt Gallen

Universitätsspital Zürich, Zurich

University Hospital, Birmingham

Beatson West of Scotland Cancer Centre, Glasgow

St John's Institute Of Dermatology - Guy's & St Thomas' Nhs Foundation Trust, London

Christie Hospital, Manchester

All Listed Sponsors
lead

4SC AG

INDUSTRY

NCT02953301 - Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS) | Biotech Hunter | Biotech Hunter